Anti-TNF therapies might reduce Alzheimer’s risk among people with rheumatoid arthritis Anti-TNF therapies commonly used to treat rheumatoid arthritis have already been found to potentially decrease the threat of developing Alzheimer’s dementia among people with rheumatoid arthritis, according to research presented this week in the American College of Rheumatology Annual Scientific Conference in Atlanta. Rheumatoid arthritis can be a chronic disease that causes discomfort, stiffness, swelling, and destruction of the joints clomidfrancais.com/le-traitement-de-l-infertilie.htm .
By two years after treatment, the average prevalence of an infection had increased to 11.3 %. The prevalence of disease varied substantially by village; 7 of the 8 villages had more infection in children at 24 months than at 2 weeks. In the remaining village, infection in kids was reduced from 36 % at baseline to 0 at all 5 subsequent visits. Villages enrolled at 12 a few months had significantly fewer attacks than those enrolled 12 months earlier. ‘Our results claim that if infection isn’t eliminated by an individual mass antibiotic treatment, after that it predictably returns into the community, at least in this hyperendemic [region of high prevalence] region in 1 – to 5-year-old children. However, infection comes back and does not strategy baseline prevalence actually by 2 years slowly,’ the authors write.